Keyword: Moderna Therapeutics
Synthorx wants a $100 million IPO, but is the window closing?
Two months after rumblings emerged that Moderna Therapeutics was prepping what would be biotech’s biggest IPO, the company has come through.
Already cash-rich, Moderna Therapeutics is said to be planning an IPO to extend its resources even further and advance its mRNA-based drugs.
Sean Harper to help run $320M VC fund; Agios crowns Jackie Fouse as CEO; and hospital-backed Civica Rx nabs Amgen vet as CEO.
Pfizer has also committed to up to $305 million in development, regulatory and commercial milestones to seal the deal.
CAR-T maker Cell Medica names Kite’s European chief as CEO; Oncorus poaches a Moderna cancer executive; and Achaogen axes R&D and its C-suite.
Oncorus has nabbed Moderna’s head of oncology development, Theodore (Ted) T. Ashburn, M.D., Ph.D., as its new chief executive and president.
Human Longevity CFO/COO departs after scandal; Sangamo loses another top executive; McCann Health fires chief creative for conduct violation and more.
On the heels of a $500M round, Moderna picked up another $125 million as it expands its cancer vaccine partnership with Merck.
Jamie Macdonald succeeds Joseph von Rickenbach as Parexel CEO, Roche promotes William Pao to replace John Reed as pRED head, Moderna loses vaccines head.